1-(2-((1R,3S,5R)-3-((S)-1-(3-chloro-2-fluorophenyl)ethylcarbamoyl)-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamide

ID: ALA4753864

PubChem CID: 162653617

Max Phase: Preclinical

Molecular Formula: C23H22ClFN6O3

Molecular Weight: 484.92

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C[C@H](NC(=O)[C@@H]1C[C@H]2C[C@H]2N1C(=O)Cn1nc(C(N)=O)c2cccnc21)c1cccc(Cl)c1F

Standard InChI:  InChI=1S/C23H22ClFN6O3/c1-11(13-4-2-6-15(24)19(13)25)28-23(34)17-9-12-8-16(12)31(17)18(32)10-30-22-14(5-3-7-27-22)20(29-30)21(26)33/h2-7,11-12,16-17H,8-10H2,1H3,(H2,26,33)(H,28,34)/t11-,12+,16+,17-/m0/s1

Standard InChI Key:  SOXWMGIJZSBBEW-SONRMIBWSA-N

Molfile:  

 
     RDKit          2D

 36 40  0  0  0  0  0  0  0  0999 V2000
    8.5128  -13.3657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5110  -14.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2252  -14.6035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9419  -14.1910    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.2224  -12.9499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9409  -13.3588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5495  -12.8050    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.2087  -12.0576    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.3923  -12.1437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8366  -11.5331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0873  -10.7491    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0301  -11.7107    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.3584  -12.9753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9055  -12.3568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7144  -12.5272    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.6477  -11.5764    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.1241  -10.9041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6362  -10.2401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9507  -10.9008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3685  -11.6148    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.1910  -11.6073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6086  -12.3214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5998  -10.8899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1983  -13.0332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6150  -13.7465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4388  -13.7438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8474  -13.0187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4312  -12.3099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3717  -13.0366    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   14.2057  -14.4636    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   10.8574  -11.3243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8511  -10.5001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1405  -10.9192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3595  -10.1833    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.3108   -9.8767    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   10.8806  -12.1505    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  1  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  9 10  1  0
 10 11  1  0
 10 12  2  0
  7 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 32  1  0
 31 16  1  0
 17 19  1  1
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  1
 22 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 22  1  0
 24 29  1  0
 25 30  1  0
 32 31  1  0
 32 33  1  0
 31 33  1  0
 19 34  2  0
 32 35  1  1
 31 36  1  1
M  END

Alternative Forms

  1. Parent:

    ALA4753864

    ---

Associated Targets(Human)

CFD Tchem Complement factor D (1353 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 484.92Molecular Weight (Monoisotopic): 484.1426AlogP: 2.19#Rotatable Bonds: 6
Polar Surface Area: 123.21Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.78CX Basic pKa: CX LogP: 1.28CX LogD: 1.28
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.55Np Likeness Score: -1.35

References

1. Cheng KJ,Hsieh CM,Nepali K,Liou JP.  (2020)  Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye.,  63  (19.0): [PMID:32482069] [10.1021/acs.jmedchem.9b01033]

Source